Tennr, the intelligent automation platform for healthcare operations, has announced a strategic partnership with Reliant Specialty Infusion as the infusion provider scales aggressively to meet growing patient demand. With Tennr’s advanced automation capabilities, Reliant Specialty Infusion aims to increase the speed of its insurance verification processes and significantly reduce script-to-seat turnaround times across its expanding network of locations.
The rising prevalence of chronic diseases, advancements in biologic therapies, and shifts in payor policies favoring outpatient settings are driving the expansion of infusion services. As infusion providers scale to meet these needs, operational efficiency has become essential to ensuring timely patient access to care.
Health Technology Insights: Castlight Launches 24/7 Virtual Urgent Care Service
“As we scale, maintaining speed and efficiency in our operations is critical,” said Kim Foret, CFO at Reliant Specialty Infusion. “Tennr’s automation technology is a game changer because we’re finally able to have efficient scalability without sacrificing the high-quality, timely care we’re known for.”
“Reliant’s growth is a testament to the quality care they provide,” said Trey Holterman, CEO at Tennr. “And Tennr is all about helping providers give fast, high quality care, so we’re excited to be the solution that’ll complement their dedication to expanding access to specialty infusion services.”
Health Technology Insights: HealthVerity, Recursion Team Up to Boost Trial Analytics
Reliant Specialty Infusion is a leading provider of specialty infusion services, dedicated to delivering patient-centered care. They have 12 locations across Louisiana, Texas and Oklahoma and plan to continue their expansion in the future.
Tennr is a New York City-based healthcare technology company dedicated to eliminating patient delays throughout the U.S. healthcare system. Founded by Stanford AI Lab and Y Combinator alumni, Tennr has raised over $60M from investors including Andreessen Horowitz (a16z) and Lightspeed Venture Partners. The company’s intelligent automation platform accelerates patient throughput, helping healthcare providers deliver more timely and effective care without adding resources.
Health Technology Insights: Avalon Secures Patent for Lab Claims Review Technology
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
